Screener / SEC EDGAR /CIK 0001766502 /10-K filed Mar 25, 2026, compared with Mar 26, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Consumer discretionary · Internet Retail

Chewy, Inc. CHWY

Compare with peers Embed
SEC comment letters, last 20 years

3 reviews of CHWY's filings by SEC staff

UPLOAD and CORRESP
Reviews 3 latest letter Jan 15, 2026
Questions asked 24 each answered in the company's own letter
No closing letter 1 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 5 UPLOAD
  2. 2. Questions in them 24 numbered comments
  3. 3. Company replies 5 CORRESP
  4. 4. Reviews closed 2 of 3 closing letter

Half the closed reviews took 21 days or less from the first letter to the closing letter.

Form 10-K

2026-01-15 to 2026-02-04 · 1 question · 1 letter from the SEC, 1 from the company
Review closed 2026-02-04
RevenueSegmentsLiquidity and cash
Note 2. Basis of Presentation and Significant Accounting Policies · Revenue Recognition, page 60
SEC asked
We note you generate revenue from the sale of pet products. We also note your emphasis on pet healthcare, including the provision of pharmacy, veterinary, and telehealth services. As it relates to these expanded service-based offerings, please explain your consideration of Rule 5-03(b) of Regulation S-X requiring separate presentation of revenue and costs of revenue from products, services and other revenues;
Rest of the question

ASC-606-10-50-5 and 606-10-55-89 through 55-91 requiring disclosure of disaggregated revenue recognized from contracts with customers into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors; and ASC 280-10-50-40 requiring separate presentation of revenues from external customers for each product and service or each group of similar products and services. We also note “Other” net sales disclosed on page 43 represents approximately 19% of net sales, making it the second largest component of net sales. Please explain the composition of your Other net sales, including whether 1. healthcare services are being presented here. To the extent any component(s) are material consider the applicability of the aforementioned guidance.

CHWY answered
The Company confirms that management considered Rule 5-03(b) of Regulation S-X and the guidance under ASC-606-10-50-5, ASC 606-10-55-89 through 55-91 and ASC 280-10-50-40 in evaluating the Company’s presentation of revenue and costs of revenue.

In evaluating the presentation of revenues and costs of revenues under Rule 5-03(b) of Regulation S-X, management considered whether the Company’s revenues from products, services, and other activities warrant separate presentation on the face of the consolidated statements of operations.
Rest of the answer

Rule 5-03(b) of Regulation S-X provides that “if income is derived from more than one of the sub-captions described under

§ 210.5-03.1, each class which is not more than 10 percent of the sum of the items may be combined with another class.” The Company’s product revenues, including pet health pharmacy-related product sales, are generated through an e-commerce ordering model and fulfilled through a shared, integrated fulfillment and logistics network. While pharmacy transactions require additional regulatory steps, the underlying activity remains the sale and fulfillment of a product. Once approved, these orders move through substantially the same fulfillment processes as other product orders, including shipping, and customer service. As a result, costs of revenue, including product procurement, inbound freight, outbound shipping, packaging, fulfillment labor, and related logistics expenses are incurred and managed on a consolidated basis. Service-related offerings included within Other net sales, such as telehealth, insurance-related offerings, and veterinary clinic services, are early-stage or ancillary in nature, rely on shared corporate infrastructure, and accounted for less than 1% of the

Company’s consolidated net sales for the fiscal year ended February 2, 2025. Accordingly, management concluded that separate presentation of revenues and costs of revenues for the services category is not required under Rule 5-03(b) of Regulation S-X, and would not provide additional useful information to investors.

In considering the guidance under ASC-606-10-50-5 and ASC 606-10-55-89 through 55-91, in addition to the above, management considered how information about the Company is presented outside its financial statements, including in its earnings releases and investor presentations. Consistent with

ASC 606-10-55-89, as described above, we believe the nature of our products is similar, as they are sourced from comparable third-party suppliers, sold in the same manner through the same sales channel, and serve the same needs of the same pet parent customer base.

In accordance with ASC 606-10-55-90, we also considered how revenue information is presented for other purposes. While we disclose a high-level composition of revenue by consumables, hardgoods, and other in MD&A, our external communications, internal reporting and reviews by our Chief Operating Decision Maker focus on our consolidated results, reflecting our emphasis on delivering a unified customer experience rather than managing the business by product category.

We further evaluated the factors outlined in ASC 606-10-55-91, including type of product, geography, customer type, contract characteristics, and sales channel, and determined these factors do not result in materially distinct economic characteristics that would warrant further disaggregation. Specifically, we considered that:

(i)

Our operations are limited to the United States with immaterial activity in Canada;

(ii)

Our customers are pet parents purchasing through the same storefront applications that provide a one-stop destination for their needs;

(iii)

Our contracts are short-term and transaction-based, and the Autoship program is non-binding and a customer can exit the program or stop shipment at any time;

(iv)

Our products, as noted above, have similar characteristics and are aimed at appealing to the same broad range of pet parent consumers;

(v)

Our products are sourced in the same manner;

(vi)

Our products have similar economic characteristics as they all exhibit low seasonality; and

(vii)

We do not maintain long-term contracts with our customers. A customer will place an order on our storefront applications, and once that distinct order has been fully shipped, we have satisfied our performance obligation to that customer and there are no remaining performance obligations with such customer.

The Company also believes that its current revenue presentation is consistent with ASC 280-10-50-40. While certain of the Company’s disclosures emphasize pet healthcare-related offerings, including veterinary and telehealth capabilities, all of these offerings are integrated into the Company’s broader platform and are intended to complement the Company’s core product sales rather than operate as standalone operating units. Pet health and specialty-related product revenues are generated through the same e-commerce ordering model and fulfilled through the Company’s shared, integrated fulfillment and logistics network as other product sales. Revenues from pet health and specialty-related products, like other products, are also recognized when the customer orders an item through the Company’s websites or mobile applications via the electronic shopping cart, funds are collected from the customer and the item is shipped from one of the Company’s fulfillment centers and delivered to the carrier.

In relation to “Other” net sales, this item represents a grouping of revenue streams that are not included within the Company’s primary consumables and hard goods categories for external reporting purposes. The largest component of Other net sales is pet health and specialty pharmacy-related, which consists of product revenue from the sale of prescription medications, other regulated pharmaceutical offerings, and certain specialty products. Pet health and specialty represented approximately 14.9% and 13% of consolidated net sales for fiscal year ended February 2, 2025 and January 28, 2024, respectively. In addition, Other net sales include private brand offerings and other individually immaterial revenues. These other revenue streams include telehealth services, pet insurance-related offerings, loyalty program memberships, and veterinary clinic services. Veterinary clinic revenues are currently nominal compared to consolidated results, reflecting the early stage of these offerings despite recent clinic openings.

While we believe the classification of “Other” is reasonable, after consideration, the Company intends to enhance its qualitative and quantitative revenue disclosures beginning with its next Form 10-K to provide additional disclosure regarding pet health and specialty product revenues included within Other net sales. The Company will (i) enhance its net sales tabular disclosure in the section titled “Component of Results of Consolidated Operations—Net Sales” as shown in the table below to provide disaggregated disclosure for net sales from pet health and specialty products and (ii) expand the narrative disclosure in the section titled “Component of Results of Consolidated Operations—Net Sales” as shown below (additions noted in bold) for illustrative purposes:

Results of Consolidated Operations—Net Sales

Net Sales

Fiscal Year

2025 vs 2024

2024 vs 2023

2025

2024

2023

$ Change

% Change

(in thousands, except percentages)

Consumables

$

Hard Goods

Pet health and specialty products

Other

Net sales

Component of Results of Consolidated Operations—Net Sales

We derive net sales primarily from sales of both third-party brand and private brand pet food, pet products, pet health and specialty products, and related shipping fees. Consumable products include retail pet food and veterinary diet products. Hard goods products include non-perishable pet supplies. Pet health and specialty products include prescription medications, non-prescription pet health care products and certain specialty animal products for categories such as equine, birds, fish, and other non-traditional pets. Other net sales include private brand sales and certain pet-related services including telehealth services, pet insurance-related offerings, loyalty program memberships, and veterinary clinic services. Revenues from these service-based offerings are not a significant component of net sales and are managed as part of the Company’s integrated platform rather than as standalone service offerings.

Sales of third-party brand and private brand pet food, pet products, pet health and specialty products, and shipping revenues are recorded when products are shipped, net of promotional discounts and refunds and allowances. Taxes collected from customers are excluded from net sales. Net sales is primarily driven by growth of new customers and active customers, and the frequency with which customers purchase and subscribe to our Autoship subscription program.

The Company will continue to evaluate the disclosure of disaggregated revenue in future filings, considering changes in its business and information regularly provided to investors.

We hope that the foregoing has been responsive to the Staff’s comment. If you have any questions related to this letter, please contact William Billings of Chewy, Inc. at (305) 302-0883 or [email protected].

Read in the reply
In its next report

First report after the company's reply of Jan 29, 2026: 10-K filed Mar 25, 2026 ↗, against the 10-K filed Mar 26, 2025 ↗.

Note 2, Basis of Presentation and Significant Accounting Policies: 20 paragraphs changed; the 3 closest in words to the question are below.

Reworded

Chewy primarily recognizes revenues from product sales when the customer orders an item through Chewy’s websites or mobile applications via the electronic shopping cart, funds are collected from the customer and the item is shipped from one of the Company’s fulfillment centers and delivered to the carrier. Certain products are shipped directly from manufacturers to Chewy customers. Chewy also recognizes revenues from certain pet-related services including telehealth services, loyalty program memberships, and veterinary clinic services. Revenues from these service-based offerings are not a material component of net sales. For all of the preceding, the Company is considered to be a principal to these transactions and revenue is recognized on a gross basis as the Company is (i) the primary entity responsible for fulfilling the promise to provide the specified products or services in the arrangement with the customer and provides the primary customer service for all products sold on through Chewy’s websites or websites, mobile applications, or veterinary clinics, (ii) has inventory risk before the products have been transferred to a customer and maintains inventory risk upon accepting returns, and (iii) has discretion in establishing the price for the specified products or services sold on through Chewy’s websites websites, mobile applications, or mobile applications. veterinary clinics.

7 words cut, 46 added sec.gov
New paragraph

The Company periodically offers gift card promotions that provide customers with a material right and are therefore accounted for as separate performance obligations. The relative standalone selling price of these promotional gift cards is deferred within accrued expenses and other liabilities based on the amount expected to be redeemed, net of estimated breakage, and recognized as revenue when the related performance obligations are satisfied or redemption becomes remote.

0 words cut, 68 added sec.gov
Reworded

Chewy determines whether it is more likely than not that a tax position will be sustained upon examination. If it is not more likely than not that a position will be sustained, no amount of benefit attributable to the position is recognized. The tax benefit of any tax position that meets the more likely than not recognition threshold is calculated as the largest amount that is more than 50% likely of being realized upon resolution of the contingency. The Company records interest related to uncertain unrecognized tax positions benefits within interest expense in the consolidated statements of operations and within other long-term liabilities on the Company’s consolidated balance sheets.

2 words cut, 2 added sec.gov

Paragraphs where only numbers, dates or period words changed are not shown. Cut words struck through, new words highlighted.

Also in this review: closing letter, 2026-02-04

Form 10-K for the Fiscal Year Ended February 2, 2020

2020-05-29 to 2020-06-19 · 4 questions · 1 letter from the SEC, 1 from the company
Review closed 2020-06-19
RevenueResults discussion (MD&A)Non-GAAP measuresDebtLiquidity and cash
Management’s Discussion and Analysis of Financial Condition and Results of Operations · Non-GAAP Financial Measures, page 37
SEC asked (1)
We note you present Adjusted EBITDA margin. Please explain to us how you have complied with Item 10(e)(1)(i)(A) of Regulation S-K in providing a presentation of equal or greater prominence, of the most directly comparable GAAP measure. Please note that this comment also applies to your presentation of the measure in Form 8-K filed April 2, 2020. Notes to Consolidated Financial Statements 1. Description of Business
CHWY answered
We respectfully acknowledge the Staff’s comment. We believe that we have complied with the stated rules and regulations relating to the presentation with an equal or greater prominence of the most directly comparable GAAP measure to Adjusted EBITDA margin. We include Adjusted EBITDA margin in the detailed GAAP to non-GAAP reconciliation for our Adjusted EBITDA calculation. The most comparable GAAP metric is net loss which is then reconciled to Adjusted EBITDA.
Rest of the answer

Moreover, we do not currently show net margin for GAAP comparisons and Adjusted EBITDA margin is purely formulaic utilizing the reconciliation provided.

In consideration of the Staff’s comment, we have provided an updated table to include the formulaic calculation of GAAP net margin (defined as GAAP net loss divided by GAAP net sales and expressed as a percentage) beginning with our press release and letter to shareholders included as part of our Form 8-K as well as our Form 10-Q for the quarterly period ended May 3, 2020, The following table has been provided for fiscal years 2019, 2018, and 2017 as a representation of our updated presentation:

($ in thousands, except percentages) Fiscal Year

Reconciliation of Net Loss to Adjusted EBITDA 2019 2018 2017

Net loss $ (252,370) $ (267,890) $ (338,057)

Add (deduct):

Depreciation and amortization 30,645 23,210 12,536

Share-based compensation expense and related taxes 136,237 14,351 11,209

Interest (income) expense, net (356) 124 206

Management fee expense(1)

1,300 1,300 866

Non-routine items (2)

— — 61,993

Transaction related costs 1,396 — —

Other 2,123 — —

Adjusted EBITDA $ (81,025) $ (228,905) $ (251,247)

Net sales $ 4,846,743 $ 3,532,837 $ 2,104,287

Net margin (5.2) % (7.6) % (16.1) %

Adjusted EBITDA margin (1.7) % (6.5) % (11.9) %

(1) Management fee expense allocated to us by PetSmart for organizational oversight and certain limited corporate functions provided by its sponsors. Although we are not a party to the agreement governing the management fee, this management fee is reflected as an expense in our consolidated financial statements.

(2) For Fiscal Year 2017, non-routine items include $33.9 million for compensation expenses to our employees as a result of PetSmart’s acquisition of us and $28.1 million of acquisition-related costs incurred for our benefit as part of PetSmart’s acquisition of us.

We define net margin as net loss divided by net sales and adjusted EBITDA margin as adjusted EBITDA divided by net sales.

Notes to Consolidated Financial Statements

1. Description of Business

Read in the reply
In its next report

First report after the company's reply of Jun 12, 2020: 10-Q filed Sep 10, 2020 ↗, against the 10-Q filed Dec 9, 2019 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Revenue Recognition, page 55
SEC asked (2)
Please tell us how you considered the requirement to disclose disaggregated revenues in accordance with ASC 606-10-50-5. In this regard, we note you generate net sales from sales of pet food, pet products, pet medications and other pet health products.
Rest of the question

We also note your disclosure of net sales from consumables, hardgoods and other in management's discussion and analysis of financial condition and results of operations on page 41 and the analysts questions regarding your pharmacy business in your fourth quarter 2019 earnings call. 5. Debt, page 60

CHWY answered
We respectfully acknowledge the Staff’s comment. We evaluated the guidance in ASC 606-10-50-5 and the related implementation guidance in ASC 606-10-55-89 through 55-91 and determined that additional disclosures of disaggregated net sales by product groups were not meaningful to allow investors to understand our business activities, historical performance, or future prospects.
Rest of the answer

When evaluating our disclosure requirements, we first look to our relationships with customers that depict the nature, amount, timing, and uncertainty of revenue and cash flows affected by economic factors.

We strive to provide the best customer experience to pet parents through our assortment of product offerings. Each product group we offer is comprised of goods specifically for pets and is aimed at appealing to the same broad range of pet parent consumers looking for a one stop shop for all of their pet needs. Additionally, our Autoship program provides pet parents the opportunity to schedule delivery of products on a consistent basis throughout the year. Sales to Autoship customers represent nearly 70% of our consolidated revenue stream and reduces the uncertainty of our revenue and cash flow streams affected by economic factors.

All products are purchased by the end customer through our storefront applications and payment is received prior to shipment. As such, revenue is recognized on a point-in-time basis for all products. Our consumables, hardgoods, and pharmaceutical products have similar economic characteristics as they all exhibit low seasonality and there has been no significant change in the mix or performance of these product groups as a percentage of total net sales or profitability. While pharmaceutical products may be slightly different as they require a prescription, a sizeable majority of the pharmaceutical products offered are consistent in nature and revenue margins with our other product lines (e.g., prescription pet food) and maintain the same characteristics with respect to the nature and timing of the revenue streams of our full catalog. Pharmaceutical products can also be included in pet parents’ Autoship orders eliminating seasonality and the uncertainty of revenue and cash flow streams. In addition, the revenues within our pharmaceutical operations are currently not material to the Company’s consolidated financial statements.

The Company strives to provide customers an appropriate mix of consumables, hardgoods, and pharmaceutical products that maximize their shopping experience. This enhances our revenue streams across the portfolio and provides margin accretion for products within each category. While we review margins across product categories, the scope of such review is limited and this is done to enhance business operations while maintaining a focus on our consolidated product offering in order to provide a full assortment of products to meet the needs of pets and pet parents.

Based on the preceding, as it pertains to ASC 606-10-55-89, we believe that the nature of products and categories across our catalog of product offerings is similar as most of the products are sourced from the same type of third party suppliers, sold in the same manner through our storefront applications, and address the same needs of the same pet parent consumers.

In accordance with ASC 606-10-55-90, we also considered how information about our revenue has been presented for other purposes:

–While we provide a summary composition in our Management Discussion and Analysis for consumables, hardgoods, and other, we do not provide discussion at that level of disaggregation. This summary is presented to provide an investor a snapshot of the composition, but as we noted above, the nature and characteristics, margins, and timing of the cash flows associated with these products are similar.

–As noted in the Staff’s comment, we do receive inquiries from investors and analysts on earnings calls specifically on the pharmaceutical business. While pharmaceutical products may be slightly different as they require a prescription, they maintain the same characteristics with respect to the nature and timing of the revenue streams as our other product offerings.

–Our shareholder letter provides financial information at the consolidated level. We do not provide detailed revenues and margins at a lower level. In our internal reporting associated with monthly and quarterly business reviews with the chief operating decision maker, our results are consolidated to align with the Company’s overarching focus on customer experience.

We also evaluated the categories stated in ASC 606-10-55-91 as part of our disclosure review process. These categories include the following:

–Type of good or service: As noted above, we provide products with similar characteristics to provide superior customer experience. These products are sourced through similar channels and maintain consistent product margins across the portfolio.

–Geographical Region: Our business operates solely in the United States.

–Market or type of customer: Our business is focused on providing pet parents in the United States a one-stop destination for their needs. Additionally, nearly 70% of our consolidated net sales are driven by our pet parents who have signed-up for our Autoship program which provides regular monthly shipments to these customers.

–Type of contract and contract duration: We do not maintain long-term contracts with our customers. A customer will place an order on our storefront applications, and once that distinct order has been fully shipped, we have satisfied our performance obligation to that customer and there are no remaining performance obligations with such customer. Our Autoship program is non-binding and a customer can exit the program or stop shipment at any time.

–Sales Channel: Our products are sold in the same manner through our storefront applications and address the same needs of the same pet parent consumer.

Therefore, we believe that disclosing the aggregate revenues for consumables, hardgoods and other pet products as a single group of similar products is in accordance with the guidance of ASC 606. Notwithstanding the preceding, the level of disaggregation is subject to re-evaluation for appropriate disclosure in the future, as necessary, due to changes to the Company or our business, either organically or through future acquisitions, divestitures, or otherwise.

5. Debt, page 60

Read in the reply
In its next report

First report after the company's reply of Jun 12, 2020: 10-Q filed Sep 10, 2020 ↗, against the 10-Q filed Dec 9, 2019 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Revenue Recognition, page 55
SEC asked (3)
We note your disclosure in Item 5 that terms of your credit facilities contain restrictions on your ability to pay dividends. Please tell us your consideration describing the most significant restrictions on the payment of dividends, indicating their pertinent provisions Please refer to Rule 4-08(e)(1) of Regulation S-X. 10. Net Loss Per Share, page 68
CHWY answered
We respectfully acknowledge the Staff’s comment. As stated in Item 5 of our Form 10-K for the fiscal year ended February 2, 2020, we do not intend to pay any cash dividends for the foreseeable future. As such and because the restrictions are customary, we do not consider it material or meaningful to investors to disclose information with respect to the specific restrictions contained in our revolving credit facility on the Company’s ability to pay dividends.

10. Net Loss Per Share, page 68
Read in the reply
In its next report

First report after the company's reply of Jun 12, 2020: 10-Q filed Sep 10, 2020 ↗, against the 10-Q filed Dec 9, 2019 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Revenue Recognition, page 55
SEC asked (4)
Please tell us your consideration of disclosing RSUs and PIUs that could potentially dilute basic loss per share in the future that were not included in the computation of diluted loss per share because to do so would have been antidilutive for the years presented. Please refer to ASC 260-10-50-1c.
CHWY answered
We respectfully acknowledge the Staff’s comment. The Company maintains one class of potentially dilutive securities issued pursuant to our 2019 Omnibus Incentive Plan (the “Chewy 2019 Plan”). The restricted stock units (RSUs) that were granted to individuals as part of the Company’s overall compensation program vest based on a defined requisite service period. A description of the Chewy 2019 Plan as well as the number of units of unvested RSUs outstanding was presented in Note 8, Share-Based Compensation of our Form 10-K for the fiscal year ended February 2, 2020.
Rest of the answer

As the Company is in a net loss position, the total number of RSUs presented are excluded from diluted net loss per share (“EPS”) as the effect would have been antidilutive.

For further clarity, we have expanded our net loss per share disclosures beginning with our Form 10-Q for the quarterly period ended May 3, 2020. We have included the number of shares of unvested RSUs (which is also disclosed in our share-based compensation footnote) that were excluded from the computation of diluted net loss per share attributable to common stockholders as the effect of such inclusion would have been antidilutive since the Company generated net losses to common stockholders.

For purposes of our comparative financials, the above disclosure is not meaningful for quarterly periods ended May 5, 2019 and earlier. As disclosed in our Form 10-K, the Company’s capital structure prior to our initial public offering is not comparable to current period presentation. The presentation of our comparative periods was previously reclassified to reflect that change. The profits interests units (PIUs) in one of the Company’s parent companies were cancelled at the date of the effectiveness of the Company’s Registration Statement on Form S-1 and disclosing such units would not be meaningful to an investor.

We hope that the foregoing has been responsive to the Staff’s comments. If you have any questions regarding this matter, please do not hesitate to contact me at (954) 334-3816 or by e-mail at [email protected].

Read in the reply
In its next report

First report after the company's reply of Jun 12, 2020: 10-Q filed Sep 10, 2020 ↗, against the 10-Q filed Dec 9, 2019 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2020-06-19

Form S-1

2019-03-08 to 2019-06-07 · 19 questions · 3 letters from the SEC, 3 from the company
No closing letter
Results discussion (MD&A)Liquidity and cashNon-GAAP measuresRevenueRisk factorsCritical estimatesInventoryAcquisitionsSegments
Prospectus Summary · Our Strengths, page 5
SEC asked (1)
Enhance your discussion of your loyal customer base to quantify your statement that your customers spend more on average the longer they remain active.
CHWY answered
The Company acknowledges the Staff’s comment and has revised the disclosures on pages 6 and 86 to enhance the discussion of the Company’s loyal customer base by quantifying the statement that customers spend more on average the longer they remain active.
Read in the reply
Risk Factors · We will remain a restricted subsidiary . . ., page 40
SEC asked (2)
You indicate that the terms of PetSmart's credit facilities and indentures "may" restrict your ability to accomplish various acts, including paying dividends, making investments, and disposing of assets. If you have certainty as to which of these activities are restricted, or under what circumstances a restriction would apply, please disclose the same to your investors.
CHWY answered
The Company acknowledges the Staff’s comment and has revised the disclosure on pages 41 and 42.
Read in the reply
Management's Discussion and Analysis of Financial Condition and Results of Operations, page
SEC asked (3)
Please disclose any known trends or uncertainties that have had, or that you reasonably expect will have, a material favorable or unfavorable impact on your net sales or your net losses. See Item 303(a)(3)(ii) of Regulation S-K.
CHWY answered
The Company acknowledges the Staff’s comment. The Company has considered Item 303(a)(3)(ii) of Regulation S-K and advises the Staff that it has disclosed the growth of our Autoship subscription program as a key driver of recurring net sales and customer retention. The Company expects that growth in

Autoship customer sales will continue to have a material favorable impact on net sales. In addition, the Company has disclosed the increasing shift from in-store to online purchases in the pet industry as a significant opportunity for growth.
Rest of the answer

The Company has also revised disclosure on pages 2 and 82 to include additional information regarding the secular shift from in-store to online purchases, which will continue to affect our growth and net sales.

In addition, the Company advises the Staff that while it believes the Company will continue a favorable upward trend in net sales as it increases its investment in advertising, launches new fulfillment centers, expands its offerings, hires additional personnel and continues to develop features on its website and mobile applications, it does not reasonably expect such a trend to have a material impact on net sales or net losses. In this regard, the Company notes that its operating expenses are expected to increase due to the launch and/or expansion of fulfillment centers and customer service centers to further grow its fulfillment and customer care capacity. Relatedly, the Company is continuing to identify and evaluate potential new fulfillment sites, which it believes will increase net sales. To the extent the Company makes the determination that it reasonably expects that such factors will have a material favorable or unfavorable impact on net sales or net losses, the Company will include the necessary disclosure in its future filings in accordance with

Item 303(a)(3)(ii) of Regulation S-K.

Read in the reply
Key Financial and Operating Data, page 54
SEC asked (4)
Please tell us why the percentage changes in net cash provided by (used in) operating activities and in free cash flow is not meaningful to your investors. We note that the percentage changes for each are larger than the other percentage changes in the chart.
CHWY answered
The Company acknowledges the Staff’s comment and has revised the disclosure on page 61.
Read in the reply
Key Financial and Operating Data, page 54
SEC asked (5)
Disclose the number of orders you have fulfilled over the periods of time presented here or, if you do not believe this metric is material to investors, please tell us why.
CHWY answered
The Company acknowledges the Staff’s request for expanded disclosure relating to the number of orders fulfilled over the periods of time presented and respectfully advises that it does not believe that it is necessary to provide additional disclosure because the number of orders fulfilled is not a relevant metric to evaluate the Company’s performance due to the variability in the number of items and average order value of each order fulfilled.
Read in the reply
Factors Affecting our Performance, page 56
SEC asked (6)
Please provide a narrative discussion of the Annual Net Sales (excluding refunds) by Cohort chart. Also, enhance the details of the chart so that the Net Sales amounts are readily quantifiable.
CHWY answered
The Company acknowledges the Staff’s comment and has revised the disclosures on page 63 to provide a narrative discussion of the Annual Net Sales (excluding refunds) by Cohort chart and has also revised the chart to clarify the Annual Net Sales (excluding refunds) by Cohort for fiscal years 2011-2014, 2015, 2016, 2017 and 2018.
Read in the reply
Factors Affecting our Performance, page 56
SEC asked (7)
Where you discuss your expected growth of brand awareness, enhance this discussion to provide quantified historical information about the costs, either on a per customer or per cohort basis, to acquire or retain your customers given that your advertising and marketing costs have remained constant as a percentage of net sales and, according to your disclosure, are expected to increase.
CHWY answered
The Company acknowledges the

Staff’s comment and has revised the disclosures on pages 66 and 67 to provide quantified historical information about the costs per cohort to acquire customers. As illustrated by the chart provided, the Company has increased its marketing spend in each period to increase customers acquired in each cohort. However, its spending on marketing has decreased relative to its annual revenue per cohort.
Read in the reply
Results of Consolidated Operations, page 60
SEC asked (8)
Revise your disclosure of your private brands to quantify the extent to which they contributed to an increase in net sales, given the role such products are expected to play in your overall growth strategy.
CHWY answered
The Company acknowledges the Staff’s comment and has revised the disclosures on pages 8 and 88 to quantify the extent to which private brands contributed to an increase in net sales.
Read in the reply
Critical Accounting Policies and Estimates, page 65
SEC asked (9)
Please clarify the extent to which your revenues relate to products that are shipped directly to customers by vendors and tell us your consideration of discussing your revenue recognition policies for these particular sales separately, including principal versus agent considerations, front and back end inventory risk for these products and the timing of revenue recognition.
CHWY answered
The Company acknowledges the Staff’s comment and has revised the disclosure on pages 76-77 to enhance the discussion of revenue recognition, which includes the principal versus agent considerations. Separately, the Company notes that it does not discuss shipments directly from vendors to customers as these transactions are de minimis in nature.
Read in the reply
Principal and Selling Stockholders, page 103
SEC asked (10)
Please identify the natural persons with voting investment power over the securities held by PetSmart and Argos Holdings. We note your disclosure elsewhere that PetSmart is a wholly-owned subsidiary of Argos Holdings and that Argos Holdings is controlled by affiliates of BC Partners. Please identify the affiliates of BC Partners and the natural persons who control them.
Rest of the question

See Item 403 of Regulation S-K and Exchange Act Rule 13d-3.

CHWY answered
The Company acknowledges the staff’s comment and respectfully advises the Staff that Chewy, Inc. is controlled by

PetSmart, Inc., which is in turn a wholly owned subsidiary of Argos Holdings L.P. Argos Holdings L.P. is controlled by its general partner, the board of directors of which comprises three or more individuals. Pursuant to the so-called “rule of three,” if voting or investment decisions with respect to issuer securities require a vote of a majority of three or more persons, none of them will be deemed the beneficial owner of those securities for purposes of Section 13(d).
Rest of the answer

See Southland Corp. (July 8, 1987). Because the board of directors of the general partner of Argos Holdings L.P. has three or more individuals, none of which exercises investment or voting control over the Company’s securities (except with respect to the shares in which he or she directly holds a pecuniary interest), none of them will be deemed the beneficial owner of those securities for purposes of Section 13(d). As such, no natural persons are required to be named in the Registration Statement

Read in the reply
Certain Relationships and Related Party Transactions, page 113
SEC asked (11)
Please provide the approximate dollar value of the amount of PetSmart's interest in each of the Master Transaction Agreement, the operating agreement related to your pharmacy operations, and the agreement governing sales of the private brand products. Please see Item 404(a)(4) of Regulation S-K.
CHWY answered
The Company acknowledges the Staff’s comment and has revised the disclosure on page 129.
Read in the reply
Consolidated Statements of Operations, page F-5
SEC asked (12)
Given the significance of the charges, please tell us your consideration of disclosing on the face of the statements of operations the amount of accretion of convertible redeemable preferred stock along with net loss attributable to common stockholders. Likewise, tell us your consideration of disclosing these amounts in both summary and selected financial data.
CHWY answered
The Company acknowledges the Staff’s comment and advises that it considered the guidance applicable to the presentation of earnings per share contained in ASC 260, Earnings per share. The Company concluded that, based on the significant changes in capitalization of the Company that occurred in connection with the Company’s equity reorganization as disclosed in Footnote 1 - Description of Business and Basis of Presentation, disclosing the amount of accretion of convertible redeemable preferred stock along with net loss attributable to common stockholders on the face of the statements of
Rest of the answer

operations as well as the summary and selected financial data would not provide investors with useful or comparable information on the performance of the Company and its businesses.

Read in the reply
Net Loss per Share, page F-27
SEC asked (13)
The computation of earnings per share for the fiscal year ended January 28, 2018 does not appear to agree with the face of the statements of operations. Please revise or advise.
CHWY answered
In response to the Staff’s comment, the Company has revised the disclosure on page F-28 of the Registration Statement to include total net loss per share for all common stockholders in order to reconcile to the presentation on the face of the statements of operations.

We hope that the foregoing has been responsive to the Staff’s comments. If you have any questions related to this letter, please contact the undersigned by telephone at (212) 446-4943 or by email at [email protected].
Read in the reply
Factors Affecting Our Performance · Efficiency of Spending on Advertising and Marketing, page 66
SEC asked (1)
We note your disclosure of lifetime value of customer (LTV) to customer acquisition cost (CAC) ratios. Please tell us your consideration of the applicability of the disclosure requirements in Item 10(e) of Regulation S-K with respect to your presentation of these ratios. In this regard, we note that the computation of LTV is based on cumulative contribution profit, which appears to be a non-GAAP measure of income.
CHWY answered
As further described in the response to comment 2 below, the Company does not consider the amounts underlying the LTV to CAC ratio, including cumulative contribution profit by cohort, to be useful or material information for separate disclosure in understanding the Company’s business, including marketing returns by cohort. Therefore, the Company does not disclose cumulative contribution profit by cohort nor aggregate contribution profit for all cohorts for any fiscal period presented.
Rest of the answer

Accordingly, the Company respectfully submits the individual cohort cumulative contribution profit as part of the LTV to CAC ratios does not require any additional disclosure under Item 10(e) of Regulation S-K and, in particular, cannot be reconciled in any meaningful way.

Read in the reply
Factors Affecting Our Performance · Efficiency of Spending on Advertising and Marketing, page 66
SEC asked (2)
Enhance your disclosure to provide the amounts that underlie the ratios you disclose. For example, provide the CAC and LTV amounts per customer, per period represented.
CHWY answered
The Company advises the Staff that it does not believe additional disclosure regarding the LTV to CAC ratios would be material to potential investors in the Company. In particular, the Company does not consider the amounts underlying the LTV and CAC ratio calculations to be material to potential investors. The Company has included the LTV to CAC ratios for its 2012-2017 cohorts to demonstrate (1) how it tracks the efficiency of its spending on advertising and marketing and (2) the similar ordering behavior of its different cohorts.
Rest of the answer

The Company’s disclosure of LTV to CAC ratios is also intended to help investors understand the Company’s history and the improvement in returns with respect to its marketing efforts by cohort. Accordingly, the Company believes it is the ratio of LTV to CAC itself which may enhance investors’ understanding of the Company and its business, rather than the amounts underlying this ratio. For these reasons, the Company has not disclosed cumulative contribution profit by cohort nor aggregate contribution profit for all cohorts for any fiscal period. The Company also believes that its results of operations data in the Registration Statement and its financial statements provide sufficient information to allow investors to assess the

Company’s performance.

Read in the reply
Principal and Selling Stockholders, page 118
SEC asked (3)
We note your response to prior comment 10. Please revise your disclosure to identify the members of the board of directors of Argos Holdings GP LLC. Please also tell us why you have not disclosed that affiliates of BC Partners are beneficial owners, given your disclosure elsewhere that such affiliates control Argos Holdings.
CHWY answered
The Company advises the Staff that the board of directors of Argos Holdings GP LLC

(“Argos GP”) is comprised of 12 individuals, including Mr. Raymond Svider, Mr. Fahim Ahmed and Mr. Michael Chang as appointees of BC Partners. Pursuant to the provisions of the organizational documents of Argos GP, these BC Partners-appointed directors can exercise majority voting power over voting and investment decisions with respect to Company securities made by the board of Argos GP. In addition, each of Messrs.
Rest of the answer

Svider, Ahmed and Chang can exercise the voting power of the other BC Partners-appointed directors if such other directors are not present at a meeting of the board of Argos GP. No other member of the board of Argos GP can exercise majority voting power. Based on the so-called “rule of three,” because voting and investment decisions with respect to issuer securities require a vote of a majority of three or more persons, none of the non-BC Partners-appointed directors will be deemed the beneficial owner of those securities for purposes of Section 13(d). See Southland Corp. (July 8, 1987). Accordingly, the Company submits that none of these other directors exercises investment or voting control over the Company’s securities (except with respect to the shares in which he or she directly holds a pecuniary interest), none of these other directors will be deemed the beneficial owner of those securities for purposes of Section 13(d) and no natural persons (other than Messrs. Svider, Ahmed and Chang) are required to be named in the Registration Statement. The Company has updated the disclosure on pages 120 and 121 to disclose that Messrs. Svider, Ahmed and Chang are members of the board of directors of Argos GP and may exercise majority voting power at meetings of the board with respect to voting and investment decisions with respect to Company securities held by Argos Holdings L.P.

The Company acknowledges the Staff’s comment regarding BC

Partners and has updated the disclosure on pages 120 and 121.

Read in the reply
Certain Relationships and Related Party Transactions, page 129
SEC asked (4)
We note your response to Comment 11. Please confirm that you will similarly update the disclosure for the Master Transaction Agreement.
CHWY answered
The Company acknowledges the Staff’s comment and has updated the disclosure on page 131.

We hope that the foregoing has been responsive to the Staff’s comments. If you have any questions related to this letter, please contact the undersigned by telephone at (212) 446-4943 or by email at [email protected].
Read in the reply
Intercompany Loan Agreements, page 79
SEC asked (1)
We note the expanded disclosure in this section. Please tell us what consideration you gave to including disclosure about this agreement in your Certain Relationships and Related Party Transactions section and to including it as an exhibit. See Items 404 and 601(b)(10) of Regulation S-K.
CHWY answered
The Company advises the Staff that it considered including disclosure about this agreement in the Certain Relationships and Related Party Transactions section and filing it as an exhibit to the Registration Statement and determined that neither was required under Items 404 and

601(b)(10) of Regulation S-K.

Instruction 4.b. to paragraph (a) of Item 404 of Regulation S-K provides that disclosure need not be provided of any indebtedness transaction for the related persons specified in Instruction 1.b. to paragraph (a) of Item 404. Instruction 1.b.
Rest of the answer

to paragraph (a) of

Item 404 provides that the term “related person” includes a security holder covered by Item 403(a) of Regulation S-K and certain family members. Accordingly, because PetSmart, Inc. (“PetSmart”) is a related person specified in Instruction 1.b. to paragraph (a) of Item 404, the Company submits that disclosure of the intercompany loan agreement and transactions pursuant to this agreement is not required in the Certain Relationships and Related Party Transactions section pursuant to Instruction 4.b. The Company notes that the existence of the intercompany loan agreement, the outstanding amount as of the most recent practicable date and the fact the agreement may be terminated in connection with this offering without cash repayment are all adequately disclosed to potential investors in the Capitalization and

Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of the Registration Statement.

The Company also submits that the intercompany loan agreement is not required to be filed as an exhibit under Item 601(b)(10) of Regulation S-K because the agreement is immaterial in both amount and significance as provided in paragraph (b)(10)(ii). First, the intercompany loan agreement is an agreement entered into in the ordinary course of business between a parent and its subsidiary, pursuant to which each party may make loans from time to time to the other for cash management purposes. Second, the amounts involved are immaterial to the Company and PetSmart. Third, as noted above, the existence of the intercompany loan agreement, the outstanding amount as of the most recent practicable date and the fact the agreement may be terminated in connection with this offering without cash repayment are all adequately disclosed to potential investors. Accordingly, the Company submits that filing this agreement is not required under Item 601(b)(10) of Regulation S-K and would not provide any material or meaningful information to investors beyond the disclosure included in the Registration Statement.

Read in the reply
Notes to Consolidated Financial Statements, page F-8
SEC asked (2)
Please tell us your consideration of providing the product group disclosures required by ASC 280-50-40; for example, revenues might be disaggregated for consumables, premium consumables, supplies and pharmacy items or on some other basis.
CHWY answered
The Company acknowledges the Staff’s comment and advises the Staff that it considered the guidance for entity-wide disclosures related to product groups under Accounting Standards Codification (ASC)

280-10-50-40 and determined that additional disclosures of disaggregated net sales by product groups were not meaningful to allow potential investors to understand its business activities, historical performance, or future prospects.
Rest of the answer

The Company believes that the nature of its products across categories are similar as the products are purchased from the same type of suppliers, sold in the same manner through the Company’s website or mobile app, and address the same needs of the same pet parent consumer. Accordingly, the Company does not believe such disclosure would be material to its potential investors.

When determining the level at which net sales by product groups should be reported under ASC 280-10-50-40, the Company first considered that its net sales principally consist of pet consumables and pet hardgoods and that net sales from other pet products are immaterial. The Company further considered the aggregation criteria in ASC 280-10-50-11 by analogy and determined the characteristics of its pet products within the consumables and hardgoods groups are similar in nature. Each product group is comprised of goods specifically for pets and are aimed at appealing to the same broad range of pet parent consumers looking for a one stop shop for all of their pet needs. The Company also considered that the consumables and hardgoods have similar economic characteristics as there is low seasonality impacts for pet consumables and pet hardgoods and there has been no significant change in the mix or performance of these product groups as a percentage of total net sales or profitability. The

Company also does not manufacture any of its products sold; rather, the finished products are procured from similar suppliers, sold via its e-commerce platform to the same type of customers and fulfilled through the same distribution network. As such, the Company considered that both product groups share similar characteristics.

Therefore, the Company believes that disclosing the aggregate revenues for all pet consumables, hardgoods and other pet products as a single group of similar products is in accordance with the guidance of ASC 280.

We hope that the foregoing has been responsive to the Staff’s comments. If you have any questions related to this letter, please contact the undersigned by telephone at (212) 446-4943 or by email at [email protected].

Read in the reply

Letters without questions

Other letters

UPLOAD and CORRESP
2 other letters: notices that a filing will not be reviewed, requests to declare a registration effective, and the like

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 14 letters filed since 2019-03-08. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CHWY/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.